Skin & hair
Chronic Hives (Lasting More Than 6 Weeks): What They Mean and What to Do
Hives that recur or never fully clear for more than six weeks are called chronic urticaria. It is a recognized medical condition, not just an allergy flare, and most cases are manageable with treatment. A dermatologist or allergist can evaluate the pattern, identify contributing factors, and guide therapy.
Talk to a clinician
Nina Osei, NP — Nurse Practitioner
checkups, refills & skin. Gale can match you with a licensed clinician for a visit.
Find care →What does 'chronic' actually mean for hives?
Clinicians use six weeks as the dividing line because most hives caused by a single trigger — a food, a drug, a virus — resolve well within that window. When hives persist or recur past six weeks, the underlying mechanism is usually different.
The formal term is chronic urticaria, divided into two main types 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction:
- Chronic spontaneous urticaria (CSU): hives with no identifiable external trigger; the most common type.
- Chronic inducible urticaria: reliably triggered by a specific physical factor — cold, heat, pressure, exercise, or scratching the skin.
Understanding which type you have shapes the treatment approach and which tests are worth ordering.
Why do hives become chronic?
In most people with chronic spontaneous urticaria, mast cells in the skin release histamine unpredictably — often through an autoimmune mechanism involving self-directed antibodies 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction. Other factors a clinician will consider include:
- Thyroid conditions: thyroid autoimmunity co-occurs with chronic spontaneous urticaria more often than chance alone would predict; studies find anti-thyroid antibodies in 10–30% of CSU patients 3Ref 3Tienforti D, Di Giulio F, Spagnolo L, et al. (2022).Chronic urticaria and thyroid autoimmunity: a meta-analysis of case-control studies.Meta-analysis confirming thyroid autoimmunity co-occurs in 10–30% of chronic spontaneous urticaria patients; supports thyroid function testing as part of workup.
- Medications: NSAIDs (ibuprofen, naproxen), aspirin, and ACE inhibitors are recognized contributors; stopping a culprit drug can sometimes resolve hives entirely 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction.
- Infections: Helicobacter pylori and other bacterial infections have been investigated as contributing factors 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction.
- Psychological stress: a well-recognized flare factor, though not a root cause 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction.
In many cases, no single cause is found even after thorough evaluation. That is frustrating but common, and it does not prevent effective treatment.
How is chronic urticaria evaluated and treated?
A dermatologist or allergist will take a careful history, examine your skin, and may order lab work — including thyroid function tests and general bloodwork 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction3Ref 3Tienforti D, Di Giulio F, Spagnolo L, et al. (2022).Chronic urticaria and thyroid autoimmunity: a meta-analysis of case-control studies.Meta-analysis confirming thyroid autoimmunity co-occurs in 10–30% of chronic spontaneous urticaria patients; supports thyroid function testing as part of workup.
Treatment typically moves through steps 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction2Ref 2Casale TB, Gimenez-Arnau AM, Bernstein JA, Holden M, Zuberbier T, Maurer M (2023).Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.Omalizumab as recommended second-line biologic for antihistamine-refractory chronic spontaneous urticaria; evidence base, dosing, and positioning in international guidelines:
1. Non-sedating antihistamines at adequate doses — the right regimen is clinician-guided, not single tablets taken on flares. 2. Dose adjustment or added antihistamines if standard doses are insufficient. 3. Omalizumab — a biologic given as an injection every four weeks, approved for chronic spontaneous urticaria that does not respond to antihistamines alone 2Ref 2Casale TB, Gimenez-Arnau AM, Bernstein JA, Holden M, Zuberbier T, Maurer M (2023).Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.Omalizumab as recommended second-line biologic for antihistamine-refractory chronic spontaneous urticaria; evidence base, dosing, and positioning in international guidelines. International guidelines now position omalizumab as first-choice second-line therapy after antihistamines 2Ref 2Casale TB, Gimenez-Arnau AM, Bernstein JA, Holden M, Zuberbier T, Maurer M (2023).Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.Omalizumab as recommended second-line biologic for antihistamine-refractory chronic spontaneous urticaria; evidence base, dosing, and positioning in international guidelines.
A symptom diary is genuinely useful. Note the time of day hives appear, how long each welt lasts, foods, new products, medications, stress, temperature exposure, and body location. Photographs with timestamps help a clinician see patterns.
One important distinction: individual hive welts that last more than 24 hours in the same spot — especially if they leave a bruise-like mark — may represent urticarial vasculitis, a different condition requiring different evaluation 1Ref 1Zuberbier T, et al. (2022).The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction.
What else could look like chronic hives?
| Possibility | When to consider it | |---|---| | Chronic spontaneous urticaria | Hives come and go unpredictably, various body locations, no consistent trigger | | Chronic inducible urticaria | Hives appear reliably after cold, pressure, exercise, or skin scratching | | Medication-related urticaria | Hives started or worsened after beginning an NSAID, ACE inhibitor, or aspirin | | Underlying autoimmune or thyroid condition | Fatigue, weight changes, or joint pain accompany the hives | | Urticarial vasculitis | Individual welts last longer than 24 hours in the same spot, or leave a bruise-like mark |
What to bring to your appointment
- A symptom diary: date, time, duration of each episode, body location
- Photos of active hives with timestamps
- A list of all current medications, vitamins, and supplements — dose and duration
- Notes on any patterns: foods, activities, stress, temperature exposure
- Any previous allergy test results or prior treatment attempts
Common questions
Can chronic hives go away on their own?
Yes — chronic urticaria does remit in many people over time, though the timeline varies from months to years. Treatment is aimed at controlling symptoms during that period. A clinician can help you track whether your hives are improving and adjust the plan accordingly.
Do I need allergy testing for chronic hives?
Not necessarily as a first step. In chronic spontaneous urticaria, a specific allergen is usually not the driver, so routine allergy testing has limited yield. A clinician will tailor workup to your specific history — thyroid testing and general bloodwork are more often useful than allergy panels in this setting.
What is omalizumab and when is it used for hives?
Omalizumab is a biologic medication (an injection given every four weeks) approved for chronic spontaneous urticaria that does not respond adequately to antihistamines. It has a strong track record for this indication and is generally well tolerated. Your dermatologist or allergist will determine whether it is appropriate for your case.
Can stress cause chronic hives?
Stress is a recognized flare trigger for chronic urticaria but is not typically a root cause on its own. Managing stress can reduce the frequency and severity of flares and is often incorporated into a complete treatment plan.
Talk to a clinician
Nina Osei, NP — Nurse Practitioner
checkups, refills & skin. Gale can match you with a licensed clinician for a visit.
Find care →When to seek urgent or emergency care
- —Throat tightness, difficulty swallowing, or a sense that your airway is narrowing — call 911 immediately
- —Lips, tongue, or face swelling (angioedema with airway involvement) — call 911
- —Dizziness, fainting, or feeling like you might pass out during a hive episode
- —Severe difficulty breathing or wheezing alongside hives
- —Hives with high fever, joint pain, or feeling profoundly unwell — warrants same-day or urgent evaluation
If you develop throat tightness, significant tongue or lip swelling, or difficulty breathing alongside hives, call 911 immediately. This may be anaphylaxis, which is life-threatening.
This article is general health information and does not constitute a diagnosis or personalized medical advice. Only a licensed clinician who has evaluated you can diagnose and treat your condition.
References
- 1.Zuberbier T, et al. (2022). The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. doi:10.1111/all.15090 ✓Classification of chronic spontaneous vs inducible urticaria; stepwise treatment approach including antihistamines; contributing factors including NSAIDs, ACE inhibitors, infections, stress; urticarial vasculitis distinction
- 2.Casale TB, Gimenez-Arnau AM, Bernstein JA, Holden M, Zuberbier T, Maurer M (2023). Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status. Dermatology and Therapy. doi:10.1007/s13555-023-01040-9 ✓Omalizumab as recommended second-line biologic for antihistamine-refractory chronic spontaneous urticaria; evidence base, dosing, and positioning in international guidelines
- 3.Tienforti D, Di Giulio F, Spagnolo L, et al. (2022). Chronic urticaria and thyroid autoimmunity: a meta-analysis of case-control studies. Journal of Endocrinology and Investigation. doi:10.1007/s40618-022-01761-2 ✓Meta-analysis confirming thyroid autoimmunity co-occurs in 10–30% of chronic spontaneous urticaria patients; supports thyroid function testing as part of workup
3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.